Fujiki M, Verner K
Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey 17033.
J Biol Chem. 1993 Jan 25;268(3):1914-20.
We have utilized a homologous cell-free mitochondrial protein import system derived from the yeast Saccharomyces cerevisiae, in addition to performing a series of in vivo experiments in yeast, to investigate the coupling between cytosolic protein synthesis and protein transport into mitochondria. We found that the import of bulk mitochondrial proteins was inhibited in both the homologous in vitro reaction and in vivo upon arrest of cytosolic protein synthesis with the addition of cycloheximide. Tight coupling of synthesis and import was also demonstrated in vivo for the beta subunit of the mitochondrial F1-ATPase. We also investigated the effect of the antifolate methotrexate on the import of a fusion protein consisting of the mitochondrial targeting signal of yeast cytochrome oxidase subunit IV fused to mouse dihydrofolate reductase (the COXIV-DHFR fusion protein). Methotrexate has previously been shown to inhibit posttranslational import of COXIV-DHFR by preventing the DHFR moiety from unfolding. However, we found that antifolate addition had no inhibitory effect on the import of COXIV-DHFR in vivo, suggesting that its import into mitochondria in yeast cells occurs cotranslationally. Further, when we treated yeast with the proton ionophore carbonyl cyanide m-chlorophenylhydrazone to collapse the mitochondrial membrane potential and induce the accumulation of extramitochondrial precursor pools, we found that the ability to be imported by a strictly posttranslational mechanism upon reestablishing the membrane potential varied from one precursor to another, suggesting that cotranslational import may be mandatory for the import of some proteins in vivo. In summary, our findings are entirely consistent with the notion that import of proteins into yeast mitochondria occurs cotranslationally under normal conditions in vivo.
我们利用了源自酿酒酵母的同源无细胞线粒体蛋白导入系统,并在酵母中进行了一系列体内实验,以研究胞质蛋白合成与蛋白转运到线粒体之间的偶联关系。我们发现,在体外同源反应和体内,添加环己酰亚胺使胞质蛋白合成停止后,大量线粒体蛋白的导入均受到抑制。线粒体F1 - ATP酶的β亚基在体内也证明了合成与导入的紧密偶联。我们还研究了抗叶酸药物甲氨蝶呤对由酵母细胞色素氧化酶亚基IV的线粒体靶向信号与小鼠二氢叶酸还原酶融合而成的融合蛋白(COXIV - DHFR融合蛋白)导入的影响。先前已表明甲氨蝶呤通过阻止二氢叶酸还原酶部分展开来抑制COXIV - DHFR的翻译后导入。然而,我们发现添加抗叶酸药物对体内COXIV - DHFR的导入没有抑制作用,这表明其在酵母细胞中导入线粒体是共翻译发生的。此外,当我们用质子离子载体羰基氰化物间氯苯腙处理酵母以破坏线粒体膜电位并诱导线粒体外前体池积累时,我们发现重新建立膜电位后通过严格翻译后机制被导入的能力因一种前体与另一种前体而异,这表明共翻译导入对于体内某些蛋白的导入可能是必需的。总之,我们的发现与以下观点完全一致,即在体内正常条件下,蛋白导入酵母线粒体是共翻译发生的。